Updated 
                  CDC HIV and TB Fact Sheet 
                  
                  
                     
                      | SUMMARY The Centers for Disease Control and Prevention (CDC) has 
                        issued a revised fact sheet on tuberculosis in people 
                        with HIV.
 | 
                  
                   Tuberculosis 
                    (TB) is common among HIV 
                    positive people, especially in resource-limited countries. 
                    It is the leading causes of mortality for people with HIV/AIDS 
                    worldwide, accounting for nearly 1 in 4 deaths.
Tuberculosis 
                    (TB) is common among HIV 
                    positive people, especially in resource-limited countries. 
                    It is the leading causes of mortality for people with HIV/AIDS 
                    worldwide, accounting for nearly 1 in 4 deaths.
                  TB 
                    bacteria can live in the body without causing symptomatic 
                    illness -- known as latent TB infection -- but can become 
                    active if the immune system is weakened. According to the 
                    CDC, HIV positive people with latent TB are 20 to 30 times 
                    more likely than HIV negative people to develop active TB 
                    disease.
                  TB 
                    is less common in the U.S., with about 4% of Americans (HIV 
                    positive and negative combined) -- or approximately 13 million 
                    people -- being infected. There were 554 deaths due to TB 
                    in 2007. But prevalence is unevenly distributed in the population, 
                    with blacks making up about 60% of HIV/TB coinfected people.
                    
                    The CDC recommends that all people newly diagnosed with HIV 
                    should be tested for TB as soon as possible, and people living 
                    with HIV and at risk for TB exposure should be tested annually 
                    to detect latent infection. 
                    
                    People with active TB disease require a combination of medications 
                    for treatment, while people with latent infection can take 
                    less intensive regimens to prevent activation. The emergence 
                    of multi-drug resistant and extensively drug resistant bacteria, 
                    however, can compromise treatment effectiveness 
                    
                    The full revised HIV and TB fact sheet is available free online 
                    at www.cdc.gov/hiv/resources/factsheets/hivtb.htm.
                    
                    6/28/11
                  Source
                    Centers 
                    for Disease Control and Prevention (CDC). National Center 
                    for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. HIV 
                    and TB. Fact sheet. Updated June 13, 2011.